spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online 17 January 2006
doi: 10.1242/jcs.02773


Journal of Cell Science 119, 459-469 (2006)
Published by The Company of Biologists 2006
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jcs.02773v1
119/3/459    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JCS
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Steiner, E.
Right arrow Articles by Berger, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Steiner, E.
Right arrow Articles by Berger, W.

Research Article

The major vault protein is responsive to and interferes with interferon-{gamma}-mediated STAT1 signals

Elisabeth Steiner, Klaus Holzmann, Christine Pirker, Leonilla Elbling, Michael Micksche, Hedwig Sutterlüty and Walter Berger*

Department of Medicine I, Institute of Cancer Research, Medical University Vienna, Borschkegasse 8a, A-1090 Vienna, Austria

* Author for correspondence (e-mail: walter.berger{at}meduniwien.ac.at)

Accepted 18 October 2005

The major vault protein (MVP) is the main component of vaults, large ribonucleoprotein particles implicated in the regulation of cellular signaling cascades and multidrug resistance. Here, we identify MVP as an interferon {gamma} (IFN-{gamma})-inducible protein. Treatment with IFN-{gamma} resulted in a significant upregulation of MVP promoter activity as well as mRNA and protein levels. Activation of MVP expression by IFN-{gamma} involved transcriptional upregulation through the JAK/STAT pathway based on an interaction of STAT1 with an interferon-{gamma}-activated site (GAS) within the proximal MVP promoter. Mutation of this site distinctly reduced basal as well as IFN-{gamma}-stimulated MVP transcription. IFN-{gamma} also significantly enhanced the translation rate of MVP. Ectopic MVP overexpression in the MVP-negative lung cancer cell model H65 led to a downregulation of three known IFN-{gamma}-regulated genes, namely ICAM-1, CD13 and CD36. Additionally, presence of MVP in H65 cells blocked both basal and IFN-{gamma}-induced ICAM-1 expression whereas downmodulation of endogenous MVP levels by shRNA enhanced IFN-{gamma}-induced ICAM-1 expression in U373 glioblastoma cells. MVP-mediated IFN-{gamma} insensitivity was accompanied by significantly reduced STAT1 phosphorylation at Y701 and diminished translocation of STAT1 into the nucleus. Summarizing, we identify MVP as an IFN-{gamma}-responsive gene interfering with IFN-{gamma}-activated JAK/STAT signals. These data further substantiate that the vault particle functions as a general interaction platform for cellular signaling cascades.

Key words: Major vault protein, MVP, Vaults, Interferon-{gamma}, STAT1, Promoter


Related articles in JCS:

Signalling platforms from the vaults

JCS 2006 119: 305. [Full Text]  



This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
H. Fischer, N. Taylor, S. Allerstorfer, M. Grusch, G. Sonvilla, K. Holzmann, U. Setinek, L. Elbling, H. Cantonati, B. Grasl-Kraupp, et al.
Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic implications and synergism with epidermal growth factor receptor inhibition
Mol. Cancer Ther., October 1, 2008; 7(10): 3408 - 3419.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Haan, C. Margue, A. Engrand, C. Rolvering, H. Schmitz-Van de Leur, P. C. Heinrich, I. Behrmann, and C. Haan
Dual Role of the Jak1 FERM and Kinase Domains in Cytokine Receptor Binding and in Stimulation-Dependent Jak Activation
J. Immunol., January 15, 2008; 180(2): 998 - 1007.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. N. Khodarev, A. J. Minn, E. V. Efimova, T. E. Darga, E. Labay, M. Beckett, H. J. Mauceri, B. Roizman, and R. R. Weichselbaum
Signal Transducer and Activator of Transcription 1 Regulates Both Cytotoxic and Prosurvival Functions in Tumor Cells
Cancer Res., October 1, 2007; 67(19): 9214 - 9220.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
M. P. Kowalski, A. Dubouix-Bourandy, M. Bajmoczi, D. E. Golan, T. Zaidi, Y. S. Coutinho-Sledge, M. P. Gygi, S. P. Gygi, E. A. C. Wiemer, and G. B. Pier
Host Resistance to Lung Infection Mediated by Major Vault Protein in Epithelial Cells
Science, July 6, 2007; 317(5834): 130 - 132.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
N. Komori, N. Takemori, H. K. Kim, A. Singh, S.-H. Hwang, R. D. Foreman, K. Chung, J. M. Chung, and H. Matsumoto
Proteomics study of neuropathic and nonneuropathic dorsal root ganglia: altered protein regulation following segmental spinal nerve ligation injury
Physiol Genomics, April 24, 2007; 29(2): 215 - 230.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Biol.Home page
K. A. Suprenant, N. Bloom, J. Fang, and G. Lushington
The major vault protein is related to the toxic anion resistance protein (TelA) family
J. Exp. Biol., March 15, 2007; 210(6): 946 - 955.
[Abstract] [Full Text] [PDF]




© The Company of Biologists Ltd 2006